Nuclear Medicine

MarketReports.com | Pharmaceuticals & Healthcare | Diagnostics | Medical Imaging |  Nuclear Medicine

Nuclear Imaging Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Price Single User $2,500.00 Site License $5,000.00 Global Site License $7,500.00 Publication Date: 30-Nov-2011 Format: PDF Pages: 180 Publisher: GlobalData More...

Nuclear Imaging Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 11-Nov-2011 Format: PDF Pages: 102 Publisher: GlobalData More...

Global Nuclear Medicine (Medical Isotopes/ Radioisotopes/ Radiopharmaceuticals) Market in PET/SPECT Imaging and Therapy - Competitive Landscape, Current trends and Forecasts (2010 – 2015) Price Single User $4,650.00 Multi User $5,650.00 Corporate Licence $7,150.00 Enterprise Site Licence $9,000.00 Publication Date: Aug-2011 Format: PDF Pages: 255 Publisher: MarketsandMarkets Table of Contents Radiopharmaceuticals are pharmaceutical agents used to diagnose certain medical problems such as cardiac, cancer, neurology, and/or treat certain conditions such as cancers. The use of radiopharmaceuticals as tracer dates back to 1930’s. Over the years, technical advancement in production, diagnostic equipments (SPECT and PET), and discovery of new radiopharmaceutical have driven the market. The global radiopharmaceuticals market for therapy and PET & SPECT imaging was valued at $3,213 million in 2010 and is expected to reach $4,734 million by 2015; growing at a CAGR of 8.1% from 2010 to 2015. The PET & SPECT diagnosis accounted for the largest share -90%- of the global radiopharmaceutical market. More...

Nuclear Imaging Equipment - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 15-Jan-2011 Format: PDF Pages: 93 Publisher: GlobalData More...

U.S. Market for Magnetic Resonance, Computed Tomography and Nuclear Medicine 2010 Price Single License Hard-Copy $6,995.00 Single License PDF $7,495.00 Corporate License PDF $8,995.00 Publication Date: Dec-2010 Pages: 149 Publisher: iData Research Table of Contents In 2009, the U.S. market for magnetic resonance (MRI), computed tomography (CT) and nuclear medicine was valued at over $5.1 billion. This market also includes contrast agents and injectors. The market declined in 2009 due to the deficit reduction act, which limited reimbursement for some imaging modalities, and the global economic recession of 2008 to 2009; however, the market is expected to recover by 2016. More...

Europe Nuclear Imaging Equipment: Market Analysis and Opportunity Assessment Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 29-Dec-2009 Format: PDF Pages: 58 Publisher: GlobalData More...

MarketReports.com | Pharmaceuticals & Healthcare | Diagnostics | Medical Imaging |  Nuclear Medicine